Empowering women to stay in science
13 April, 2015 by Janette WoodhouseIn Australia, there is a loss of female talent in the scientific workforce resulting in a chronic under-representation of women, particularly in senior positions.
Empowering women to stay in science
13 April, 2015 by Janette Woodhouse
In Australia, there is a loss of female talent in the scientific workforce resulting in a chronic under-representation of women, particularly in senior positions.
Mid-cap biotech companies increase revenues to $26.5 billion
09 April, 2015Research and consulting firm GlobalData has released a report comparing the competitive positions of 35 mid-cap biotechnology companies, finding an increase in combined total revenues from $24.8 billion in 2013 to $26.5 billion in 2014.
DKSH appointed exclusive Setaram distributor
01 April, 2015Setaram Instrumentation has announced DKSH Australia as its new exclusive representative in Australia and New Zealand.
Technology-commercialisation skills study awarded grant
01 April, 2015The Professional Standards Councils (PSC) will fund a year-long study to identify the skills and qualities required to successfully put research to use via commercialisation.
NHMRC recognises top research translation centres
30 March, 2015In order to encourage leadership at an internationally competitive level, the National Health and Medical has recognised four Australian health centres as NHMRC Advanced Health Research and Translation Centres.
Sigma-Aldrich signs exclusive distribution agreement with Roche
24 March, 2015Following an exclusive distribution agreement signed last week, life science company Sigma-Aldrich will employ its sales, marketing and e-commerce expertise for the exclusive worldwide distribution of the Biochemical Reagents product portfolio from Roche.
Scientists to converge on Sydney for annual ARCS congress
23 March, 2015The 2015 ARCS Sydney Scientific Congress will once again offer one of the premier events of the year for professionals in the development and commercialisation of therapeutics.
Why is there no generic insulin?
23 March, 2015Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US.
Scientists said to be tweaking their experiments
23 March, 2015 by Lauren DavisAustralian researchers have stated that some scientists are unknowingly tweaking experiments and analysis methods in order to increase their chances of obtaining easily publishable results.
Why is there no generic insulin?
23 March, 2015Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US.
QIAGEN acquires circulating tumour cell technology
17 March, 2015QIAGEN has expanded its portfolio of liquid biopsies through the acquisition of an innovative technology that enables enrichment and molecular analysis of circulating tumour cells (CTCs) from blood samples.
CureVac investors to accelerate vaccine development
10 March, 2015The Bill & Melinda Gates Foundation will invest $52 million in biopharma company CureVac, as well as supply separate funding for several projects to develop prophylactic vaccines based on the company's messenger RNA (mRNA) platform.
New Grand Challenges grant opportunities
05 March, 2015The Bill & Melinda Gates Foundation, along with its partners in the Grand Challenges initiative, is currently accepting applications for various upcoming grant programs.
BD and Cellular Research jointly promote single-cell sequencing products
03 March, 2015BD Life Sciences is teaming up with biotechnology company Cellular Research to jointly promote the businesses' solutions for highly multiplexed cell isolation and single-cell gene expression analysis.
